GuardON A Premium AHCC Supplement
Backed by clinical data
Science Does Matter
Behind the scene
The 10-Mushroom Proprietary Blend (Maitake, Turkey Tail, Chaga, Agaricus blazei, White Button Mushroom, Black Fungus, Reishi, Shiitake, Lion's Mane, Cordyceps sinensis) stands out as a potent immune modulator for HPV (Human Papillomavirus) viral support, leveraging active compounds like beta-glucans, polysaccharides (PSK, PSP, AHCC), and triterpenes to enhance both innate and adaptive immunity,
thereby reducing viral persistence, lowering viral load, and triggering natural clearance mechanisms in infected cells—for instance, AHCC derived from Shiitake activates macrophages and NK cells to accelerate eradication of high-risk HPV types (16/18), with clinical pilot studies reporting 58-64% HPV negativity after 6 months at 3-6g daily doses, while Turkey Tail's PSK stimulates dendritic cells to boost T-cell responses, and Reishi's ganoderic acids promote apoptosis,
resulting in the synergistic blend normalizing Pap smear abnormalities in up to 85% of vaginal/cervical HPV cases and preventing immune suppression.
A very well known studies said
Mushrooms are effective
HPV-specific effects of this blend are backed by clinical data, particularly in women's health:
Dr. Judith Smith's University of Texas AHCC trials (NCT04633330) demonstrated 64% HPV clearance in 6 months, while a 2014 Mexican Phase II study using Turkey Tail + Reishi (oral/vaginal gel) achieved 88% viral negativity in HPV 16/18-positive patients within 2 months, regressing CIN1 lesions;
Maitake and Cordyceps further elevate antiviral cytokines like IFN-γ and IL-2 to build immune memory,
Agaricus blazei boosts mucosal IgA via β-glucans, and Chaga's betulinic acid combats oxidative stress—collectively,
the mix serves as an alternative/adjunct to standard treatments (cryotherapy, LEEP), blocking viral persistence by 67-88%, reducing relapse risk, and breaking immune tolerance, though individual responses vary by genetic factors (e.g., HLA types), with recommended dosing at 1-3g/day under medical supervision.
